BackKuros Biosciences AG Overview

Kuros Biosciences AG Receivables

Track Kuros Biosciences AG's receivables ($36M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$35.85M
↑ 33.35% YoYΔ $8.97M vs prior year quarter

Peer trimmed avg / median

Loading

Kuros Biosciences AG Receivables History

Loading

Kuros Biosciences AG vs. peers: Receivables Comparison

Loading

Kuros Biosciences AG Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kuros Biosciences AG (CSBTF) FAQ

As of the most recent data (June 2026), CSBTF shows a receivables of $36M. That compares with $27M in the prior-year period — up 33.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CSBTF's receivables is now $36M (was $27M) — a 33.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Kuros Biosciences AG is outperforming or lagging.

Tracking CSBTF's receivables over time shows whether Kuros Biosciences AG is scaling, shrinking, or reshaping that part of the business. The current reading is $36M That compares with $27M in the prior-year period — up 33.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Kuros Biosciences AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $36M) with ownership activity and broader fundamentals.